Cell-free production of trimeric influenza hemagglutinin head domain proteins as vaccine antigens
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cell-free production of trimeric influenza hemagglutinin head domain proteins as vaccine antigens
Authors
Keywords
-
Journal
BIOTECHNOLOGY AND BIOENGINEERING
Volume 109, Issue 12, Pages 2962-2969
Publisher
Wiley
Online
2012-06-22
DOI
10.1002/bit.24581
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Surface Functionalization of Virus-Like Particles by Direct Conjugation Using Azide−Alkyne Click Chemistry
- (2011) Kedar G. Patel et al. BIOCONJUGATE CHEMISTRY
- Microscale to manufacturing scale-up of cell-free cytokine production-a new approach for shortening protein production development timelines
- (2011) James F. Zawada et al. BIOTECHNOLOGY AND BIOENGINEERING
- Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies
- (2011) Sanae Sasaki et al. JOURNAL OF CLINICAL INVESTIGATION
- Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial
- (2011) P Noel Barrett et al. LANCET
- Site-Specific Incorporation ofp-Propargyloxyphenylalanine in a Cell-Free Environment for Direct Protein−Protein Click Conjugation
- (2010) Bradley C. Bundy et al. BIOCONJUGATE CHEMISTRY
- Plasmablast-derived polyclonal antibody response after influenza vaccination
- (2010) Xiao-Song He et al. JOURNAL OF IMMUNOLOGICAL METHODS
- The Receptor-Binding Domain of Influenza Virus Hemagglutinin Produced in Escherichia coli Folds into Its Native, Immunogenic Structure
- (2010) R. M. DuBois et al. JOURNAL OF VIROLOGY
- Specific Recognition of Influenza A/H1N1/2009 Antibodies in Human Serum: A Simple Virus-Free ELISA Method
- (2010) Mario M. Alvarez et al. PLoS One
- An Influenza A/H1N1/2009 Hemagglutinin Vaccine Produced in Escherichia coli
- (2010) José M. Aguilar-Yáñez et al. PLoS One
- Properly Folded Bacterially Expressed H1N1 Hemagglutinin Globular Head and Ectodomain Vaccines Protect Ferrets against H1N1 Pandemic Influenza Virus
- (2010) Surender Khurana et al. PLoS One
- The 2009 A (H1N1) influenza virus pandemic: A review
- (2010) Marc P. Girard et al. VACCINE
- Cell-free production of Gaussia princeps luciferase – antibody fragment bioconjugates for ex vivo detection of tumor cells
- (2009) Kedar G. Patel et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Tyrosine, Cysteine, and S-Adenosyl Methionine Stimulate In Vitro [FeFe] Hydrogenase Activation
- (2009) Jon M. Kuchenreuther et al. PLoS One
- Antibody Recognition of a Highly Conserved Influenza Virus Epitope
- (2009) D. C. Ekiert et al. SCIENCE
- Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virus
- (2009) Zuzana Biesova et al. VACCINE
- Superior efficacy of a recombinant flagellin:H5N1 HA globular head vaccine is determined by the placement of the globular head within flagellin
- (2009) Langzhou Song et al. VACCINE
- High-level cell-free synthesis yields of proteins containing site-specific non-natural amino acids
- (2008) Aaron R. Goerke et al. BIOTECHNOLOGY AND BIOENGINEERING
- Comparative Efficacy of Neutralizing Antibodies Elicited by Recombinant Hemagglutinin Proteins from Avian H5N1 Influenza Virus
- (2008) C.-J. Wei et al. JOURNAL OF VIROLOGY
- Efficacious Recombinant Influenza Vaccines Produced by High Yield Bacterial Expression: A Solution to Global Pandemic and Seasonal Needs
- (2008) Langzhou Song et al. PLoS One
- An Economical Method for Cell-Free Protein Synthesis using Glucose and Nucleoside Monophosphates
- (2005) Kara A. Calhoun et al. BIOTECHNOLOGY PROGRESS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started